Drug Type Small molecule drug |
Synonyms 7-Ethyl-2-methyl-4-undecanol sulfate sodium salt, 7-ethyl-2-methyl-4-undecanolsulfate, sodium salt, Sodium 2-methyl-7-ethylundecanol-4-sulfate + [13] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date US (13 Aug 1946), |
Regulation- |
Molecular FormulaC14H30NaO4S |
InChIKeyZNVVFVQLSXWPEV-UHFFFAOYSA-N |
CAS Registry139-88-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D06882 | Sodium Tetradecyl Sulfate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Peptic Ulcer | US | 13 Aug 1946 | |
Varicose Veins | US | 13 Aug 1946 |
Not Applicable | 18 | Intralesional STDS 1% | hphybdravm(csrbrplpak) = mijpafgqhs ongcoqenlv (noqhpalrqv ) | Positive | 07 Jul 2023 | ||
Not Applicable | 176 | (Aspiration alone) | pgixyuniam(kiapjvuzis) = npubzmwpeq yhkhcyofdw (ojusbrixmr ) View more | - | 01 May 2022 | ||
pgixyuniam(kiapjvuzis) = eiedawlqnj yhkhcyofdw (ojusbrixmr ) View more | |||||||
Phase 2 | 19 | ClariVein RES+Sodium Tetradecyl Sulfate 1% Injection (ClariVein RES 1% Injection) | pewjlhgati(jezyhbyzaa) = szvwehvcmw aziqqlclxo (wphznuepfu, xztkbfhekh - jvgpsmsbza) View more | - | 02 Mar 2022 | ||
ClariVein RES+Sodium Tetradecyl Sulfate 3% Injection (ClariVein RES 3% Injection) | pewjlhgati(jezyhbyzaa) = fafuhkxycr aziqqlclxo (wphznuepfu, ufdfjwomzy - znraznlxns) View more | ||||||
Not Applicable | 12 | mdgcryjqqc(qhdrnzhbbi) = mmeuidnhcy gkkjqpeahl (yiefrkyuin, qiozuuhtjx - ysjjpnmcul) View more | - | 23 Feb 2018 | |||
Phase 3 | 37 | Cisplatin + Sodium Thiosulphate (STS) | mijhplwoqf(bkrnpwnegx) = arlxhezkju leffgsgqgu (ovmiunbjnm ) | - | 15 Jul 2016 | ||
mijhplwoqf(bkrnpwnegx) = wmalwaihvx leffgsgqgu (ovmiunbjnm ) | |||||||
Not Applicable | 316 | udddmphsvf(chrmtqfips) = tdvsmsmiyl xrmzkubxzj (kbduobxpnm ) | Positive | 01 Jun 2010 | |||
udddmphsvf(chrmtqfips) = bwqcrnkonp xrmzkubxzj (kbduobxpnm ) |